HUP0004369A3 - The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration - Google Patents

The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration

Info

Publication number
HUP0004369A3
HUP0004369A3 HU0004369A HUP0004369A HUP0004369A3 HU P0004369 A3 HUP0004369 A3 HU P0004369A3 HU 0004369 A HU0004369 A HU 0004369A HU P0004369 A HUP0004369 A HU P0004369A HU P0004369 A3 HUP0004369 A3 HU P0004369A3
Authority
HU
Hungary
Prior art keywords
neural
substituted aminomethyl
chroman derivatives
promote
prevent
Prior art date
Application number
HU0004369A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HUP0004369A2 publication Critical patent/HUP0004369A2/hu
Publication of HUP0004369A3 publication Critical patent/HUP0004369A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0004369A 1997-11-24 1998-11-11 The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration HUP0004369A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19751949A DE19751949A1 (de) 1997-11-24 1997-11-24 Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
PCT/EP1998/007197 WO1999026621A1 (de) 1997-11-24 1998-11-11 Verwendung von substituierten aminomethyl-chromanen zur verhinderung der neuronalen degeneration und zur förderung der neuronalen regeneration

Publications (2)

Publication Number Publication Date
HUP0004369A2 HUP0004369A2 (hu) 2001-04-28
HUP0004369A3 true HUP0004369A3 (en) 2002-04-29

Family

ID=7849618

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004369A HUP0004369A3 (en) 1997-11-24 1998-11-11 The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration

Country Status (30)

Country Link
US (2) US6235774B1 (https=)
EP (1) EP1051170B1 (https=)
JP (1) JP2001523716A (https=)
KR (1) KR20010032357A (https=)
CN (1) CN1134256C (https=)
AR (1) AR016973A1 (https=)
AT (1) ATE206615T1 (https=)
AU (1) AU745759B2 (https=)
BG (1) BG64167B1 (https=)
CA (1) CA2311126A1 (https=)
DE (2) DE19751949A1 (https=)
DK (1) DK1051170T3 (https=)
ES (1) ES2164465T3 (https=)
HN (1) HN1998000169A (https=)
HU (1) HUP0004369A3 (https=)
IL (1) IL135904A (https=)
IS (1) IS5496A (https=)
MY (1) MY118414A (https=)
NO (1) NO20002638L (https=)
NZ (1) NZ504656A (https=)
PE (1) PE134999A1 (https=)
PL (1) PL340674A1 (https=)
PT (1) PT1051170E (https=)
RU (1) RU2217140C2 (https=)
SI (1) SI1051170T1 (https=)
SV (1) SV1998000138A (https=)
TR (1) TR200001471T2 (https=)
TW (1) TW524690B (https=)
WO (1) WO1999026621A1 (https=)
ZA (1) ZA9810668B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
BR0109193A (pt) * 2000-03-17 2003-05-27 Alcon Inc Compostos com atividade agonista 5-ht2 e 5-ht1a para tratamento do glaucoma
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
SE0004455D0 (sv) * 2000-12-01 2000-12-01 Milos Pekny Method for neuron regeneration in the central nervous system
DE10101917A1 (de) * 2001-01-16 2002-07-18 Bayer Ag Verwendung von Chromanen
AU2002355170B2 (en) * 2001-07-26 2007-06-07 Merck Patent Gmbh Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
BR0212199A (pt) * 2001-09-12 2004-10-05 Merck Patent Gmbh Uso de aminometil cromanos substituìdos no tratamento de distúrbios do movimento
DE10155075A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
WO2005033092A1 (en) 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Chroman derivatives
DE102004017627A1 (de) * 2004-04-10 2005-10-27 Bayer Healthcare Ag Verwendung von vollen 5-HT1A-Agonisten zur Hemmung der opiat/opioid-induzierten Atemdepression
UA125519C2 (uk) 2016-07-29 2022-04-13 Суновіон Фармасьютікалз Інк. Сполуки і композиції і їх застосування
CA3032141A1 (en) 2016-07-29 2018-02-01 Vadim ALEXANDROV Compounds and compositions and uses thereof
RU2651756C1 (ru) * 2017-05-10 2018-04-23 Федеральное государственное бюджетное образовательное учреждение Высшего Образования Кубанский Государственный Медицинский Университет Министерства Здравоохранения Российской Федерации, КубГМУ Препарат для предотвращения образования глиальных рубцов
BR112020001433A2 (pt) 2017-08-02 2020-07-28 Sunovion Pharmaceuticals Inc. compostos de isocromano e usos dos mesmos
MX2021010880A (es) 2019-03-14 2022-01-18 Sunovion Pharmaceuticals Inc Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300523A (en) 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE19522088A1 (de) 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration

Also Published As

Publication number Publication date
ZA9810668B (en) 1999-05-26
NO20002638D0 (no) 2000-05-23
WO1999026621A1 (de) 1999-06-03
BG104466A (en) 2001-02-28
HUP0004369A2 (hu) 2001-04-28
US20010018530A1 (en) 2001-08-30
SI1051170T1 (en) 2001-12-31
PE134999A1 (es) 2000-03-05
DK1051170T3 (da) 2001-12-27
MY118414A (en) 2004-10-30
PL340674A1 (en) 2001-02-12
AR016973A1 (es) 2001-08-01
BG64167B1 (bg) 2004-03-31
RU2217140C2 (ru) 2003-11-27
CN1279604A (zh) 2001-01-10
EP1051170A1 (de) 2000-11-15
EP1051170B1 (de) 2001-10-10
HN1998000169A (es) 1999-11-03
NZ504656A (en) 2002-02-01
TR200001471T2 (tr) 2000-10-23
AU745759B2 (en) 2002-03-28
US6235774B1 (en) 2001-05-22
ATE206615T1 (de) 2001-10-15
KR20010032357A (ko) 2001-04-16
IL135904A0 (en) 2001-05-20
TW524690B (en) 2003-03-21
JP2001523716A (ja) 2001-11-27
US6331561B2 (en) 2001-12-18
SV1998000138A (es) 1999-05-25
DE19751949A1 (de) 1999-05-27
AU1668599A (en) 1999-06-15
IS5496A (is) 2000-05-15
PT1051170E (pt) 2002-02-28
CN1134256C (zh) 2004-01-14
CA2311126A1 (en) 1999-06-03
IL135904A (en) 2003-07-06
NO20002638L (no) 2000-05-23
DE59801724D1 (de) 2001-11-15
ES2164465T3 (es) 2002-02-16

Similar Documents

Publication Publication Date Title
PL336290A1 (en) Sulphonamides for treating endothelin-involving disorders
HUP0004369A3 (en) The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration
DE69812391D1 (en) Cyclopentaphenanthrenyl-titan-komplexe und polymerisationsverfahren
GB9927379D0 (en) Emulsion for well and formation treatment
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
GB9702194D0 (en) Sulphonide derivatives
HUP0100519A3 (en) Method for preparing derivatives of the taxoid class
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
HUP9904335A3 (en) Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
AU5703399A (en) Promoters of neural regeneration
GB9720291D0 (en) Filters
GB2321457B (en) 5-Aroylnaphthalene derivatives
HU9502722D0 (en) Amino-methyl-phosphonic- and amino-methyl-phosphinic-acid derivatives and their use for treating degenerative membrum diseases
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
GB9715821D0 (en) Amidino-camptothecin derivatives
GB9705200D0 (en) Well treatment with particles
HU9800247D0 (en) Promoter for human endoglingene and its use
GB2326779B (en) Fail-safe system
EP1032559A4 (en) AMINO-ALKYLPHENOL DERIVATIVES AND ASSOCIATED COMPOUNDS
EP0976720A4 (en) propanolamine
GB9725541D0 (en) Amino-benzothiazole derivatives
IL134494A0 (en) 13-deoxyanthracycline derivatives and processes for preparing them
GB9705071D0 (en) Nebuliser
GB9727165D0 (en) Filters
ZA988065B (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives